Notice: Undefined index: action in /home/impactinvesting/public_html/wp-content/themes/voice-child/functions.php on line 2
JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating | MarketScreener – Impact investing

3. GOOD HEALTH AND WELL-BEING

JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating | MarketScreener

6 months ago

Add Comment

by Amanda

1 Views

1 min read

Written by Amanda

05/26/2023 | 10:22am EDT

All news about THE BEAUTY HEALTH COMPANY

Analyst Recommendations on THE BEAUTY HEALTH COMPANY

Financials (USD)

Sales 2023	465 M – –
Net income 2023	14,5 M – –
Net Debt 2023	173 M – –
P/E ratio 2023	105x
Yield 2023	–

Capitalization	1 283 M 1 283 M –
EV / Sales 2023	3,13x
EV / Sales 2024	2,53x
Nbr of Employees	1 034
Free-Float	98,8%

Chart THE BEAUTY HEALTH COMPANY

Duration :

Period :

Technical analysis trends THE BEAUTY HEALTH COMPANY

	Short Term	Mid-Term	Long Term
Trends	Bearish	Neutral	Neutral

Income Statement Evolution

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell Buy
Mean consensus	BUY
Number of Analysts	11
Last Close Price	9,67 $
Average target price	18,11 $
Spread / Average Target	87,3%

EPS Revisions

Please enable JavaScript in your browser’s settings to use dynamic charts.

Managers and Directors

Sector and Competitors

Source: marketscreener.com